Literature DB >> 18573452

Brain metastases secondary to tumor emboli from primary lung cancer during lobectomy.

Yasushi Cho1, Yasuhiro Hida, Kichizo Kaga, Hiroaki Kato, Mikiya Iizuka, Satoshi Kondo.   

Abstract

It is assumed that dissemination of tumor cells during pulmonary resection may be followed by metastases. A 70-year-old man with pleomorphic carcinoma of the lung had brain metastases develop secondary to brain infarction caused by tumor emboli during lobectomy. This is a rare case that clearly showed brain metastases as a consequence of tumor emboli during pulmonary resection.

Entities:  

Mesh:

Year:  2008        PMID: 18573452     DOI: 10.1016/j.athoracsur.2008.01.029

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Effects of vessel interruption sequence during thoracoscopic lobectomy for non-small cell lung cancer.

Authors:  Ryota Sumitomo; Takamasa Fukui; Satoshi Marumo; Yosuke Otake; Cheng-Long Huang
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-05-25

2.  Curative Effects of Different Sequences of Vessel Interruption During the Completely Thoracoscopic Lobectomy on Early Stage Non-Small Cell Lung Cancer.

Authors:  Fengwei Li; Guanchao Jiang; Yingtai Chen; Jun Wang
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-08-18       Impact factor: 1.520

3.  Pleomorphic carcinoma of the lung with high serum beta-human chorionic gonadotropin level and gynecomastia.

Authors:  Kerem Okutur; Baris Hasbal; Kubra Aydin; Mustafa Bozkurt; Esat Namal; Buge Oz; Kamil Kaynak; Gokhan Demir
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

4.  Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer.

Authors:  Masaki Hashimoto; Fumihiro Tanaka; Kazue Yoneda; Teruhisa Takuwa; Seiji Matsumoto; Yoshitomo Okumura; Nobuyuki Kondo; Tohru Tsujimura; Takashi Nakano; Seiki Hasegawa
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.